Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.

Journal: European urology focus
Published Date: Jun 11, 2019

Abstract

The Charlson comorbidity index is an outdated comorbidity assessment tool which is not disease specific and is not applicable to contemporary BCa patients.

Authors

  • Edward Lambert
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium. Electronic address: edward.lambert@ugent.be.
  • Frederiek D'Hondt
    General Surgery and Urology. OLV Hospital. Belgium.
  • Elio Mazzone
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium; ORSI Academy, Melle, Belgium.
  • Jonathan Vollemaere
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
  • Alessandro Larcher
    Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Jolien Van Der Jeugt
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
  • Gaetan Devos
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
  • Pieter Uvin
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
  • Marijn Goossens
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
  • Filip Poelaert
    Department of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium.
  • Geert De Naeyer
    General Surgery and Urology. OLV Hospital. Belgium.
  • Peter Schatteman
    General Surgery and Urology. OLV Hospital. Belgium.
  • Justin Collins
    ORSI Academy, Melle, Belgium.
  • Alexandre Mottrie
    ORSI Academy Melle Belgium.
  • Paolo Dell'Oglio
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.

Keywords

External Resources

Popular Topics
Recent Journals